参见附件。
【摘要】目的探讨糖类抗原125(CA125)在子宫内膜癌患者血清中的表达及其与临床病理参数的相关性。方法采用酶联免疫吸附法(ELISA)检测103例子宫内膜癌患者血清中CA125的表达。结果共检出CA125阳性患者32例，阳性表达率为31.1%。Ⅰ期患者的CA125阳性表达率为11.1%，Ⅱ期的CA125阳性表达率为19.4%，Ⅰ期和Ⅱ期比较差异无统计学意义(P>0.05)；Ⅲ期的CA125阳性表达率为77.8%，显著高于Ⅰ期和Ⅱ期(P0.05)。结论CA125在子宫内膜癌血清中呈高表达，并且与临床分期和组织学分级密切相关。检测血清CA125的阳性表达可以为子宫内膜癌的早期诊断、干预和预后提供参考。
【关键词】血清糖类抗原125；子宫内膜癌；酶联免疫吸附法Expression and clinical significance of serum CA125 in patient with endometrial carcinoma LIU Yun-hua.The People’s Hospital of Peng’an Country,Peng’an 637800,China
【Abstract】ObjectiveTo explore the expression and clinical significance of serum CA125 in patient with endometrial carcinoma (EC),study the correlation of CA125 expression between clinic pathological parameters ......
